• Molecular NameLonidamine
  • SynonymNA
  • Weight321.163
  • Drugbank_IDDB06266
  • ACS_NO50264-69-2
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)4.36
  • pkaN/A
  • LogD (pH=7, predicted)2.07
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-1.98
  • LogSw (predicted, AB/LogsW2.0)0.0
  • Sw (mg/ml) (predicted, ACD/Labs)0.03
  • No.of HBond Donors1
  • No.of HBond Acceptors4
  • No.of Rotatable Bonds3
  • TPSA55.12
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyLonidamine has been used in the treatment of brain tumours in combination with radiotherapy and temozolomide.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A